Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment
Dimitrios N. Sidiropoulos, Christine I. Rafie, Julie K. Jang, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 656-669
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer
Anna Bianchi, Iago De Castro Silva, Nilesh Deshpande, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1428-1453
Open Access | Times Cited: 67
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
Evanthia T. Roussos Torres, Won Jin Ho, Ludmila Danilova, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 866-879
Closed Access | Times Cited: 16
The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy
Brendan Moran, Maria Davern, John V. Reynolds, et al.
Cancer Letters (2023) Vol. 559, pp. 216121-216121
Open Access | Times Cited: 39
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Menglei Jin, Jun Fang, Jiakuan Peng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
STAT3: Key targets of growth-promoting receptor positive breast cancer
Ruiyuan Jiang, Jiayu Zhu, Huanping Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
Hong Zheng, Minghao Wang, Shiyu Zhang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 14, pp. 4689-4708
Open Access | Times Cited: 15
The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
Ruiyang Ren, Chenyi Xiong, R.C-S. Ma, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 14
Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer
Jun Liu, Jiaye Lu, Ling Wu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
Chidamide improves gefitinib treatment outcomes in NSCLC by attenuating recruitment and immunosuppressive function of myeloid-derived suppressor cells
Jinjin Shao, Zhichao Ye, Zeren Shen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116306-116306
Open Access | Times Cited: 5
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial
Marina Baretti, Ludmila Danilova, Jennifer N. Durham, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
Jesse Kreger, Evanthia T. Roussos Torres, Adam L. MacLean
Cancer Immunology Research (2023) Vol. 11, Iss. 5, pp. 614-628
Open Access | Times Cited: 12
YAP/STAT3 inhibited CD8+ T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor‐associated macrophages
Chen Wang, Ningning Shen, Qingling Guo, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16295-16309
Open Access | Times Cited: 11
Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment
Xinpu Han, Xiaotong Song, Z. G. Xiao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Deciphering the role of CNIH4 in pan-cancer landscapes and its significance in breast cancer progression
Xu Yao, Zengzhen Lai, Chaolin Li
Frontiers in Genetics (2025) Vol. 16
Open Access
NK cell immunopotentiators-loaded nanoliposomes enhance ADCC effect for targeted therapy against HER2-positive breast cancer
Ruoxin Du, Changqing Cao, Fan Dong, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Mechanisms of tumor-associated macrophages in breast cancer and treatment strategy
Hong Jin, Xinyue Meng, Jianwei Feng
Frontiers in Immunology (2025) Vol. 16
Open Access
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F. Santibáñez
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Harnessing Histone Deacetylase Inhibitors for Enhanced Cancer Immunotherapy
Fatemeh Hedayat, Elnaz Faghfuri
European Journal of Pharmacology (2025) Vol. 997, pp. 177620-177620
Closed Access
Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles
Wenlu Yan, Haijun Yu, Yiting Zou, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 17826-17844
Closed Access | Times Cited: 10
Personalized tumor combination therapy optimization using the single-cell transcriptome
Chen Tang, Shaliu Fu, Xuan Jin, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Hypoxic Memory Mediates Prolonged Tumor Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression
Oihana Iriondo, Desirea Mecenas, Yilin Li, et al.
Cancer Research (2024) Vol. 84, Iss. 19, pp. 3141-3157
Closed Access | Times Cited: 3
Age‐Dependent Regulation of Hippocampal Inflammation by the Mitochondrial Translocator Protein in Mice
Kei Onn Lai, Jia Hui Wong, Nevin Tham, et al.
Aging Cell (2025)
Open Access
Multiomics Empowers Predictive Pancreatic Cancer Immunotherapy
Janelle M. Montagne, Elizabeth M. Jaffee, Elana J. Fertig
The Journal of Immunology (2023) Vol. 210, Iss. 7, pp. 859-868
Open Access | Times Cited: 9
Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo
Karin Schelch, Dominik Emminger, Benjamin Zitta, et al.
Cancer Letters (2023) Vol. 574, pp. 216395-216395
Open Access | Times Cited: 8
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer
Robert Hsu, Batul Al-zubeidy, Daniel Flores, et al.
Breast Cancer Research and Treatment (2024) Vol. 206, Iss. 2, pp. 245-259
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top